S&P Announces New International Rating for BaxterMarch 05, 2013
March 5, 2013
Baxter International Inc., a U.S. based medical products company has announced its acquisition of Gambro AB for $4 billion. In line with this acquisition S&P, an American financial services company adjusted Baxter’s international rating to “A”.
The acquisition will be financed with an estimated $1 billion of overseas cash and proceeds from $3 billion of new debt. According to S&P, the additional debt is the main factor in changing Baxter’s corporate credit and unsecured rating. S&P also categorized Baxter as an “intermediate” when it comes to their financial risk profile.
With the new rating, Baxter continues to reflect a strong business profile and renowned to be the leading manufacturer of different medical products such as infusion pumps.
Companies such as Baxter International develop smart infusion pump systems which helped medical institutions and clinicians deliver medication accurately and safely, improving both patient care and safety. It is essential for healthcare facilities to only use properly-serviced infusion pump systems.
AIV provides replacement parts and repair services for most leading infusion pumps, including Baxter IV pumps. For the full line of AIV’s infusion pump parts and services, go to http://www.aiv-inc.com/iv-infusion-pump-replacement-parts.html.
About the Author
AIV CatalogRequest Your Printed or Electronic Copy Today!
Be Part of Our
Healthcare technology management professionals are a vital link in hospital operations, and we proudly support the national, state, and local associations with ongoing support and resources.Get Biomed Resources
Why buy from AIV
AIV strives to provide you cost effective options to service equipment. We offer flexible solutions to best suit your needs.